• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·002312.SZ
Share

Sichuan Development Lomon Co.,Ltd. Stocks

CN¥ 8.14Last Updated 09.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 2.30B

CN¥ 8.14
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Sichuan Development Lomon Co., Ltd. is a Chinese enterprise primarily engaged in offering outsourced financial solutions. The company assists the banking sector by streamlining operational procedures, implementing centralized platform governance, and providing data-driven analytics and services based on big data. Furthermore, it manufactures a range of phosphorus-based chemical products, including industrial-grade monoammonium phosphate, calcium hydrogen phosphate for animal feed, and fertilizer-grade monoammonium phosphate. Established in 1997, the firm, initially named Chengdu Santai Holding Group Co., Ltd., is headquartered in Chengdu, China.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, of fair value o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 002312.SZ is 12.0 and suggests 47.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 17:26

Deeply Unpopular Stocks: Strategist Recommends Stocks to Ride Out the Sell-Off

09.10.2026 17:15

Shares of biotech company Pacira soared 44%: the maker of "Viagra" is set to acquire it

09.10.2026 16:48

The crisis in France could affect other countries. Which bonds are investors watching?

09.10.2026 16:34

Exxon Has Blocked a Settlement Agreement on the Kashagan Environmental Fine – Media Reports

09.10.2026 15:28

Morning in New York: A New Stress Test for the AI Rally

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026